NXTC Earnings

Quarterly EPS
$-4.95
Q3 2024
$-4.97
Q4 2024
$-4.70
Q1 2025
$-11.29
Q2 2025
$-3.22
Q3 2025
$-2.37
Q4 2025
$-1.87
Q1 2026
$-2.80
Q2 2026
Latest RevenueN/A
Latest Net Income-14892000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$2.800-14892000+75.2%
Q1 2026-$1.870-9796000+60.2%
Q4 2025-$2.370-9436000+52.3%
Q3 2025-$3.220-8624000+34.9%
Q2 2025-$11.290-26808000-70.8%
Q1 2025-$4.700-10976000+35.8%
Q4 2024-$4.970-11603000+20.1%
Q3 2024-$4.950-11540000+19.1%
Q2 2024-$6.610-15404000
Q1 2024-$7.320-17107000
Q4 2023-$6.220-14467000
Q3 2023-$6.120-14301000
NextCure (NXTC) — Earnings